Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Leukemia 4Rectal Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Lymphocytic, Chronic, B-Cell 3Colorectal Neoplasms 3Colonic Neoplasms 3Waldenstrom Macroglobulinemia 2Small Cell Lung Carcinoma 2Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms, Plasma Cell 2Neoplasms 2Multiple Myeloma 2Melanoma 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Carcinoma, Renal Cell 2Wilms Tumor 1Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Skin Neoplasms 1Ovarian Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1

Interventions

Irinotecan 30Paclitaxel 24Gemcitabine 21Cisplatin 21Docetaxel 19Fluorouracil 15alvocidib 12Oxaliplatin 11Leucovorin 11Carboplatin 11Capecitabine 11Bortezomib 9Taxes 8Topotecan 73-aminopyridine-2-carboxaldehyde thiosemicarbazone 7Vorinostat 6Immunohistochemistry 6tanespimycin 5Temozolomide 5Sorafenib 5Pemetrexed 5Early Intervention, Educational 5Chromatography, High Pressure Liquid 5Bevacizumab 57-hydroxystaurosporine 57-cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine 5ixabepilone 4bryostatin 1 4Sirolimus 4Pharmacogenomic Testing 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Unspecified Adult Solid Tumor, Protocol Specific × oblimersen × Clear all
NCT00054548 2013-05-16

Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
55 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡